Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 September 2021 | Story Michelle Nöthling | Photo Supplied
Peet Jacobs.

Peet Jacobs is no stranger to the Deaf community in and around the UFS and Bloemfontein. He has been working at the University of the Free State (UFS) for the past six years, and he is still amazed at the amount of support our institution provides to Deaf students in particular, and to South African Sign Language (SASL) in general. “They provide excellent interpreting services,” Peet says, “not only in face-to-face classes, but also on different online platforms, as well as interpreting pre-recorded lectures and videos.” And as a SASL interpreter, Peet is an integral part of this service. 

But signing is not merely a day job for Peet. He carries his skill into the community in his spare time, where he assists as an interpreter at hospitals, doctors’ rooms, and psychiatrists’ offices – to name but a few. What gives Peet the deepest satisfaction, however, is when he can combine his love of Sign Language with his love of the Bible and his God. It was actually Peet’s devotion to his religion that inspired him to learn Sign Language in order to enable him to carry the Word of God into the Deaf community. Peet now also presents Bible courses in SASL and assists a non-profit organisation to produce SASL Bible-based publications, which are translated and recorded in video format. 

Peet aspires to become an authority on SASL subject-specific vocabulary related to subject in higher education. “Sign Language is a language in its own right,” Peet points out. “The uniqueness of Deaf culture and the variety of dialects within SASL give the language diversity and colour.” Peet goes on to emphasise how important it is that SASL is recognised as an official language in our country. “This recognition will give dignity to a group of people who have been marginalised in South Africa. This will also pave the way to providing more inclusivity and service to the Deaf community.”

Until then, Peet will continue to serve the best way he knows how: through signing.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept